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LysineCell-penetrating peptides (CPPs) gain access to intracellular compartments mainly via endocytosis and have
capacity to deliver macromolecular cargo into cells. Although the involvement of various endocytic routes has
been described it is still unclear which interactions are involved in eliciting an uptake response and to what
extent afﬁnity for particular cell surface components may determine the efﬁciency of a particular CPP.
Previous biophysical studies of the interaction between CPPs and either lipid vesicles or soluble sugar-mimics
of cell surface proteoglycans, the two most commonly suggested CPP binding targets, have not allowed
quantitative correlations to be established. We here explore the use of plasma membrane vesicles (PMVs)
derived from cultured mammalian cells as cell surface models in biophysical experiments. Further, we
examine the relationship between afﬁnity for PMVs and uptake into live cells using the CPP penetratin and
two analogs enriched in arginines and lysines respectively. We show, using centrifugation to sediment PMVs,
that the amount of peptide in the pellet fraction correlates linearly with the degree of cell internalization and
that the relative efﬁciency of all-arginine and all-lysine variants of penetratin can be ascribed to their
respective cell surface afﬁnities. Our data show differences between arginine- and lysine-rich variants of
penetratin that has not been previously accounted for in studies using lipid vesicles. Our data also indicate
greater differences in binding afﬁnity to PMVs than to heparin, a commonly used cell surface proteoglycan
mimic. Taken together, this suggests that the cell surface interactions of CPPs are dependent on several cell
surface moieties and their molecular organization on the plasma membrane.ese hamster ovarian cell; CPP,
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Cell-penetrating peptides (CPPs) have received attention as
intracellular delivery vectors due to their ability to enter cells and
gain access to interior compartments even when in complex with
macromolecular cargoes [1,2]. Uptake pathways of CPPs have been at
center of attention ever since the ﬁrst CPPs were identiﬁed more than
20 years ago [3–5]. Early studies focused on cell membrane penetra-
tion [6–11] and although this is still a suggested pathway for some
arginine-rich CPPs [12–14], it has become increasingly clear that
endocytosis is the predominant route of entry [2,12,15–17]. Recently,
we and others have reported that CPPs are not only endocytosed
passively upon cell-surface association, but instead also trigger their
own uptake by speciﬁcally stimulating macropinocytosis [18–21].Moreover, we have shown a qualitative relation between an increased
rate of macropinocytosis and the extent of uptake of the CPP
penetratin [21]. However, details of the molecular interactions that
result in internalization remain poorly understood. CPP uptake
appears independent of chiral receptors [22,23] but recent evidence
indicate that cell surface proteoglycans (PGs), in particular heparan
sulfates (HSPGs), play important roles[24–27], potentially acting as
primary CPP binding sites [28,29]. CPP-induced clustering of HSPG
chains may initiate intracellular signaling cascades resulting in
endocytosis [30] and recently, Wittrup et al. identiﬁed a speciﬁc
HSPG epitope that was necessary for endocytic stimulation to which
the CPP Tat was able to bind [31].
Most CPPs are positively charged and interact readily with
negatively charged cell surface moieties. However, positive charge
as such is not sufﬁcient for efﬁcient internalization, but instead the
type of charged residue is crucial. Peptides with a high content of
arginines are generally more potent than corresponding peptides
containing lysines [13,32]. This superior uptake-promoting ability of
arginines has been ascribed to the guanidinium head-groupwhich can
form stable bidentate hydrogen-bonded ion-pairs with oxoanions on
the cell surface [32–35]. We previously investigated the relative
importance of arginine and lysine for uptake and intracellular
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integrity, induced peptide secondary structure, and hydrophobic
partitioning using a set of designed CPP sequences [7,9,36–39].
Although more efﬁcient uptake of arginine-rich CPP versions was
conﬁrmed, we saw only weak correlations between peptide-lipid
interaction and uptake [14,21,36]. Furthermore, in a comparative
study of amino acid afﬁnity for heparin (a soluble HS mimic), it was
reported that arginine has only a 2–3 fold stronger binding afﬁnity
than lysine. A similarly small difference in afﬁnity was found when
comparing a heptaargininewith a c-terminal tryptophan (R7W) to the
corresponding heptalysine (K7W) [40]. These variations also appear to
be insufﬁcient to account for differences in cellular uptake for
arginine- and lysine homopolymers of similar amino acid composition
[13,32]. This prompted us to explore the interaction between CPPs
and cell-derived plasma membrane vesicles as models of the surface
of a living cell. The advantage of using such vesicles, compared to
investigate cell-surface binding to whole cells, is that cell surface
binding can be assessed independent of endocytosis and that the
vesicles can be adapted to a wider range of biophysical experiments.
PMVs can be released from cultured adherent cells upon chemical
treatment [41–43]. They contain all major classes of naturally
occurring cell surface components including lipids, membrane pro-
teins, glycolipids, and glycoproteins. Therefore, their overall compo-
sition is representative of the plasma membrane from which
they were derived [43]. We treated Chinese hamster ovary cells
CHO-K1 with formaldehyde (FA) and dithiothreitol (DTT) to obtain
micrometer-sized vesicles. Similarly prepared vesicles have been used
to study membrane phase separation [44], membrane protein
proteomics [45], lipid–protein interaction [46] or used as membrane
source for nanotechnological applications [47].
Despite that a relation between the amount of CPP bound to the
cell surface and its degree of internalization seems intuitively obvious,
it is currently not clear whether this classical description of adsorptive
endocytosis [48] also applies to CPPs. Drin et al. [49] proposed that
uptake of penetratin may be governed by such mechanisms based on
competition experiments where poly-lysine was added to block cell
surface binding sites. However, other groups have subsequently
suggested that a connection between cell-surface binding and uptake
efﬁciency does not exist [50,51]. Here we compared the afﬁnity of
penetratin for PMVs to its total cellular uptake established in previous
work [21]. To speciﬁcally address differences between arginines and
lysines we further compared penetratin to its all-arginine and all-
lysine versions PenArg and PenLys (Table 1) [14,21,36–38]. All ex-
periments in this study were performed using FITC-labeled peptides.
Confocal microscopy was used to visualize the binding of penetratin
peptides to PMVs and to characterize the PMVs as amembranemodel.
Binding afﬁnity was estimated by subjecting PMVs, incubated with
various concentrations of peptide, to centrifugation to separate PMVs
from buffer and thus obtain a measure of the amount of bound
peptide. When comparing these data to the total cellular uptake we
identiﬁed a virtually linear correlation between PMV binding and
cellular internalization, which is mainly endocytic [14,21]. This
indicates that internalization can be directly related to the amount
of peptide associated with the cell surface, in accord with a classical
adsorptive endocytic uptake mechanism. This ﬁnding provides a
straight-forward explanation to one of the physico-chemical factorsTable 1
Peptide sequences.
Peptide Sequence
Penetratin FITC-GABA-RQIK IWFQ NRRM KWKK-NH2
PenArg FITC-GABA-RQIR IWFQ NRRM RWRR-NH2
PenLys FITC-GABA-KQIK IWFQ NKKM KWKK-NH2
Arginines are marked in bold and lysines underlined.governing CPP efﬁcacy and seen in a wider perspective, this could
facilitate the design of new CPPs or improvements of existing ones,
providing an engineering approach to the development of functional
peptide-based drug delivery vectors.
2. Materials and methods
2.1. Cell culture
Chinese hamster ovarian cells CHO-K1 were cultured in Ham's F-
12 media, with fetal bovine serum (10%) and L-glutamine (2 mM)
(PAA Laboratories) in humidiﬁed atmosphere at 37 °C and 5% CO2. At
~75–85% conﬂuence, cells were trypsinized and re-seeded at a density
of ~12,000 cells/cm2 (every 3–4 days). For preparation of plasma
membrane vesicles (PMVs), cells were cultured to conﬂuence
(typically 4.5 days). Cell media was replaced 8 h before addition of
vesiculation-inducing chemicals to ensure cells being in good
condition.
2.2. Preparation of plasma membrane vesicles
Vesiculation was induced by treating CHO-K1 cells with formalde-
hyde (FA) and dithiothreitol (DTT) (Sigma) essentially following the
procedures described by Bauer et al. [45]. Prior to treatment, the cells
were washed twice in HEPES buffered saline (HBS; 10 mM HEPES,
142 mM NaCl, 1.3 mM CaCl2, pH 7.4). Vesiculation reagents were
freshly dissolved and diluted inHBS buffer, themixturewas preheated
to 37 °C and added to cell culture ﬂasks so that cells were just covered
in solution. The cells were then incubated for 15 h at 37 °C on a rocking
table at 125 rpm. Plasmamembrane vesicles (PMVs)were collected by
pipetting off the vesiculation buffer, care taken not to detach cells
from the culture ﬂask. The PMV solution was ﬁltered through a
Sephadex G-25 de-salting column (GE Healthcare) to remove vesicu-
lation chemicals. Based on the vesiculation rate estimated by Bauer et al.
[45], the PMV concentration was in the order of 107 vesicles/ml. For all
experiments, the PMV solution was used without further dilution or
subfractioning and on the day of preparation.
2.3. Confocal microscopy
Plasma membrane vesicles (PMVs) were deposited on a coverslip
in a 50 μl droplet and allowed to settle for 15 min prior to addition of a
small volume of FITC-labeled peptide (NeoMPS, purity N80%)
dissolved in deionized water, to the top of the droplet. No mixing
was done as this causes the vesicles to move and makes it impossible
to image early events of CPP–PMV interaction. The peptide was
instead allowed to mix with the sample by diffusion. The added
amount of peptide corresponded to a ﬁnal peptide concentration of
5 μM in the droplet. Vesicles were monitored continuously until
peptide had diffused to the plane of the PMVs, typically taking 5–
10 min. Confocal images were thereafter acquired using either a TCS
SP (equipped with a HCX PL APO CS 63× objective) or a TCS SP2 RS
(equipped with as APO CS 63×/1.2 W CORR objective) confocal laser
scanning microscope system from Leica. The 488 nm line of an Ar ion
laser was used to excite the FITC-labeled peptides, carboxyﬂuorescein
(CF) (Sigma) and SYTO® RNASelect™ (Invitrogen). The 543 nm line
from a HeNe laser was used to excite FM4-64(N-(3-triethylammo-
niumpropyl)-4-(6-(4-(diethylamino)phenyl)hexatrienyl)pyridinium
dibromide, Invitrogen). Fluorophores were added to the PMV samples
as described for the peptides and concentrations are indicated in the
ﬁgure legends. All experiments were repeated at least 3 times.
PMVs do not adhere well to a glass coverslip and to decrease
movement of vesicles and thereby obtain an acceptable image quality
we spin-coated coverslips prior to experiments with SU-8 (10%,
MicroChem) at 2300 rpm for 60 s. Coverslips were thereafter baked
Fig. 1. Plasma membrane vesicles (PMVs). (A, B) CHO-K1 cells treated with vesiculation chemicals producing PMVs. (C) Gel ﬁltration-puriﬁed PMVs harvested after 15 h of
vesiculation. Scale bar=10 μm.
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~100 mJ/cm2) and baked a second time at ~95 °C for 60 s.
2.4. Quantitation of peptide binding to plasma membrane vesicles
The PMV solution was divided into 500 μl aliquots and FITC-
labeled peptides (penetratin, PenArg or PenLys, 1, 5 or 10 μM) added
to each sample. Samples were mixed gently and 250 μl was
transferred to a 96-well plate as reference for the total amount of
peptide in each sample (ctot). Remaining volumes were incubated for
15 min at room temperature, followed by 20 min centrifugation at
50,000 g to separate bound (pellet) and free (supernatant) peptide.
The supernatant was transferred to a 96-well plate. Pellets were
redissolved in 250 μl HBS. A SpectraMax M2 plate reader (Molecular
Devices) was used to read the FITC absorbance at 495 nm. All samples
were corrected for background contributions by subtraction of the
absorbance value of the buffer. The pellet fraction was not readily
redissolved and the bound fraction was therefore taken as the
difference between total amount of peptide and the peptide in the
supernatant. Penetratin is known to have a tendency to adhere toFig. 2. Time-lapse confocal imaging of penetratin-PMV interactions. (A–D) Images acquired
Mixing was by diffusion. Diffusion-limited peptide binding kinetics, but also peptide intern
proﬁles along the line indicated in (A). Scale bar=10 μm.plastics in tubes, pipette tips etc. [52], but control experiments in
absence of PMVs, showed that peptide adsorption was not a problem.3. Results and discussion
3.1. Characteristics of plasma membrane vesicles
Plasma membrane vesicles (PMVs) can be released from cultured
cells by addition of formaldehyde (FA) and dithiothreitol (DTT) [45].
Fig. 1(A–B) shows CHO-K1 cells that release spherical, unilamellar
PMVs with considerably less contrast than the cells, in agreement
with that they contain cytosolic ﬂuid but no organelles [43]. The PMVs
bud off uniformly from the cell surface. Fig. 1C shows PMVs harvested
from cells in culture after 15 h exposure to 25 mM FA and 2 mM DTT.
The PMVs were separated from vesiculation chemicals, cell debris and
othermacromolecular structures on a Sephadex G-25 buffer exchange
gel ﬁltration column. Puriﬁed vesicles were spherical, unilamellar and
approximately 5–10 μm in diameter, and the solution was virtually
free from cell debris.10, 20, 30 and 40 min after addition of 5 μM penetratin to a droplet sample of PMVs.
alization and appearance of membrane fragments can be seen over time. (E) Intensity
Fig. 3. PMV membrane integrity and contents. (A–D) Staining with membrane marker
FM4-64 (20 μg/ml) and external addition of carboxyﬂuorescein (CF, 5 μM). Images
acquired in two separate experiments 10 min (upper panels) and 50 min (middle
panels) after addition of the dyes. (E, F) Staining with FM4-64 (20 μg/ml) and RNA-
speciﬁc SYTO RNASelect (3 μM) acquired after 5 min incubation. Intensity proﬁles along
the lines indicated in the confocal images are shown in panels to the right. Scale
bar=5 μm.
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We examined interactions between FITC-labeled penetratin and
PMVs by confocal microscopy. A small aliquot of peptide was added to
a droplet sample where PMVs had been allowed to settle onto a
coverslip. Fig. 2 shows a representative series of confocal images, with
corresponding intensity proﬁles for one vesicle, visualizing the time
course of events following peptide addition. After 10 min, penetratin
has diffused from the edge of the droplet to the site of the PMVs and
membrane binding is then immediately observed. A few PMVs appear
to directly internalize peptide. This may be due to membrane
instability but could also be an apparent effect as all vesicles do not
reside with their “equator” in the confocal plane and some
contribution from membrane-associated ﬂuorescence is thus
expected. From 20 min onwards, the intensity from the membrane
increases only marginally indicating that mixing by diffusion is
complete and that equilibrium between bulk and membrane is
established. Upon further incubation, accumulation inside the PMVs
becomes more pronounced.
We noticed that vesicles occasionally detached from the coverslip
during the time-course of the experiment, due to motion in the
sample. Non-vesicular membrane fragments with bound peptide
appeared after longer periods of incubation, indicating that penetratin
may cause some vesicular lysis or PMV collapse. The number of PMVs
in each frame of Fig. 2 increases because the PMVs do not ﬁrmly
adhere to the coverslip and due to that additional vesicles settle onto
the coverslip with time. To reduce initial image acquisition problems,
due to vesicle mobility, we coated coverslips with hydrophobic SU-8.
We cannot exclude that this may enhance destabilization of PMVs.
Due to difﬁculties in imaging vesicles and in stringently distinguishing
internalized from membrane-bound peptide, no quantitative infor-
mation was extracted from these images.
3.3. PMVs are impermeable to ﬂuid-phase markers and contain RNA
The observation of some penetratin inside the PMVs prompted us
to investigate further the stability and intravesicular contents of
PMVs. Staining with the cell-impermeable membrane probe FM4-64
which is only ﬂuorescent when bound to membranes [53] resulted, in
most cases, in bright ﬂuorescence exclusively from the PMV
membranes (Fig. 3). Occasionally, diffuse intravesicular ﬂuorescence
or lipid inclusions (~1 μm in diameter) were observed indicating that
the PMV lumen may contain trace amounts of lipids. The occasional
intravesicular FM4-64 staining suggests that the integrity of the PMV
membrane is less strict than in a living cell, and that this, normally
cell-impermeable, dye can in fact traverse these model membranes
[53]. Vesicle leakiness was further tested by adding water-soluble
carboxyﬂuorescein (CF) to monitor ﬂuid-phase exchange over the
PMV membrane (Figs. 3A–D). CF was not internalized in samples
incubated for 10 min and only to a minor extent in samples incubated
for 50 min. Presence of CF in concentrations similar to those used in
the peptide experiments did not cause vesicle rupture as observed
with the former (Fig. 2). Since penetratin was observed to accumulate
inside PMVs they must contain molecules for which the peptide has
some afﬁnity. Staining with the RNA speciﬁc probe SYTO RNASelect
(Figs. 3E–F) conﬁrmed presence of RNA in agreement with that PMVs
contain cytosolic ﬂuid [43].
The data above suggest that whereas the PMVs appear somewhat
permeable to lipid-bindingmolecules such as the FM4-64dye, they are
not intrinsically leaky, since CF cannot enter and RNA is only observed
inside the vesicles and thus efﬁciently conﬁned. Penetratin binds
avidly to the membrane and is apparently thereafter able to
translocate. This is in accord with some previous observations in
model systems [6,11,54] but in contrast with other [7–9]. We believe
that the translocation into PMVs is exaggerated compared to
translocation across the plasma membrane of a live cell because ofthe metastable nature of the PMVs and it is unclear to us whether this
phenomenon would be relevant to describe uptake of penetratin in
live cells, which is, in addition, mainly endocytic [14,21]. However, the
ﬁnding that penetratin has a tendency to disrupt PMV membranes
with time (Fig. 2) indicates that the mechanism by which it
translocates is invasive and that if this occurred in a live cell it would
result in cytotoxicity. Except for PenArg added at high concentrations,
penetratin variants are consistently reported to benontoxic [21,55,56].
3.4. Inﬂuence of arginine and lysine on peptide binding to PMVs
The differences between arginines and lysines in terms of
promoting cellular uptake are well established for penetratin as well
as for other CPPs [13,14,21,32], but have previously not been
quantitatively understood from biophysical experiments [7,9,36–
40,57]. Fig. 4 shows representative confocal images of PMVs recorded
15 min after addition of FITC-labeled versions of penetratin. The all-
arginine PenArg peptide and penetratin bind with an even distribu-
tion to PMV membranes in accord with previous ﬁndings [6–9]. The
Fig. 4. Penetratin analogs displaying different patterns of binding to PMVs. (A) PenLys,
(B) Penetratin, (C) PenArg. PenArg and penetratin show clear membrane association,
while PenLys gives more diffuse ﬂuorescence with no clear membrane localization.
Images acquired 15 min after addition of peptide. Contrast and gain have been
optimized for each image and the intensities are thus not directly comparable. Scale
bar=5 μm.
Fig. 5. Quantitation of peptide binding to PMVs. (A) Concentration of peptide prior to
centrifugation (gray bars), in the supernatant (light gray bars) and in the pellet (dark
gray bars). Error bars represent maximum and minimum values from experiments
performed in duplicates. (B) Binding curves showing concentration in the pellet
fraction (calculated as ctot−csupernatant) as a function of total peptide in each sample.
Solid lines represent binding to PMV harvested and puriﬁed from CHO-K1 cells as
described in the text. Dotted lines represent binding to PMVs that had been subjected to
5 cycles of freeze-thawing prior to puriﬁcation on a gel ﬁltration column and addition of
peptide. The procedure removes intravesicular RNA.
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more diffuse intravesicular ﬂuorescence, in agreement with its lesser
ability to enter live CHO-K1 cells [21] and apparent inability to enter
PC-12 or V79 cells [14].
While confocal imaging of peptide-PMV interaction gives a good
qualitative view of how these peptides behave in presence of PMVs it
was not feasible to obtain quantitative data of peptide binding from
intensity analysis of these images (see above). Instead, we used
centrifugal sedimentation to separate the PMVs from buffer and
thereby estimate the amount of bound peptide. Sedimentation of the
PMVs could be obtained at 5000 g as established by examining the
supernatant for absence of vesicles and in agreement with similar
data on PMVs from HEK293 cells [58]. However, to ensure efﬁcient
separation, samples were centrifuged at 50,000 g for 20 min (see
Fig. S1 for images of FM4-64 stained pellet and supernatant fractions).
For PenArg, the absolute concentration in the supernatant was very
low showing that this peptide sedimented almost completely with the
PMVs whereas samples containing PenLys, prepared under identical
conditions, showed a signiﬁcant amount of peptide in the supernatant
(see below).
The peptide concentration in pellet and supernatant fractions was
quantiﬁed spectrophotometrically from the absorbance of the FITC
label. Fig. 5A shows the distribution of peptide between the
supernatant and the pellet fraction upon addition of 10 μM peptide
to a PMV sample. The concentration of peptide in the supernatant is inthe order PenLysNpenetratinNPenArg, and vice versa for the concen-
tration of peptide in the pellet, as expected from previous afﬁnity
studies in lipid membranes [9,36,38]. The total amount of peptide in
the supernatant and the pellet fractions do not add up to the total
amount added to the sample. This is due to that the pellet could not be
completely dissolved. This leads to an underestimation of the amount
of peptide in the pellet fraction, a problem that we have encountered
before, albeit using a different macromolecular system [59].We
estimate that up to 25% of the total amount of added peptide could
not be recovered. Therefore, the amount of peptide in the pellet
fraction was determined indirectly as the difference between the total
amount of peptide initially present in each sample and the amount of
peptide in the supernatant (ctot−csupernatant).
Fig. 5B shows the calculated amount of peptide in the pellet
fraction as function of total peptide concentration. As we did observe
peptide translocation and subsequent accumulation in the PMVs
(Fig. 2) we wanted to ensure that the data in Fig. 5 were re-
presentative of plasma membrane binding and that the amount of
bound peptide was not overestimated due to intravesicular peptide
binding (i.e. to RNA, see Fig. 3). Samples were therefore gently mixed
to avoid potential vesicle rupture and then incubated for only 15 min
Fig. 6. Relation between peptide uptake and membrane binding. Total uptake in live
cells as a function of peptide in the pellet fraction (Fig. 5B). Cells and PMVs were
subjected to 1, 5 or 10 μMpeptide. Error bars represent minimum andmaximum values
in each experiment. Linear correlation is seen for all three peptides, with importance of
arginines emphasized for both uptake and binding. Cell uptake data was retrieved from
Reference [21].
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internalization that we observed in Fig. 2. We also set aside half of the
PMV suspension used to record the data in Fig. 5 and subjected these
PMVs to ﬁve freeze-thaw cycles (liquid N2/37 °C) followed by gel
ﬁltration prior to addition of peptide. Freeze-thawing will cause
vesicles to open up and reseal and consequently release intravesicular
content [60]. Furthermore, we observed that this procedure reduced
the size of the PMVs (data not shown), which is consistent with a
simultaneous release of contents. The gel ﬁltration step thereafter
removes released RNA. Binding curves from these experiments are
shown as dashed lines in Fig. 5B and are within experimental error
identical to those obtained from untreated vesicles. This shows that
peptide internalization, as observed in the confocal experiments, does
not signiﬁcantly contribute to the material found in the pellet.
The data in Fig. 5B clearly shows that arginine residues have higher
afﬁnity for the PMVs than lysine residues. At the highest peptide
concentration 90% of the added PenArg is bound to the vesicles while
only 15% of PenLys is bound. Since neither the exact nature, nor the
concentration of these binding sites is known, binding constants
cannot be directly extracted from these data, but an estimation of a
binding constant ratio (KPA/KPL) between PenArg (PA) and PenLys
(PL) to PMV binding sites (B) can still be obtained for a generalized
case based on a simple binding equilibrium:
KPA
KPL
=
PA½ bound
PA½ free B½ free;PA
×
PL½ free B½ freePL
PL½ bound
: ð1Þ
We used the experimentally determined bound and free peptide
concentrations from Fig. 5B to estimate possible values for the
quotient KPA/KPL in Eq. (1). If the available binding sites on the PMV
surface are in excess, this quotient will approach its lowest possible
value which is KPA/KPL ~34. If the available binding sites are instead
limited the quotient will be even higher (see derivation in
Supplementary information). The same is true for the relations
between PenArg and penetratin or penetratin and PenLys and the
lowest values of those binding constant quotients are KPA/KPen ~5 and
KPen/KPL ~7 respectively. We and others have attempted to obtain a
physico-chemical understanding of the differences in uptake efﬁcien-
cy of arginine- and lysine-rich cell-penetrating peptides by comparing
their afﬁnities for lipid vesicles of varying composition [9,36,38], their
water–octanol/chloroform partitioning [32–34,37], or their ability to
bind soluble fractions of heparan sulfates or heparin [40,61]. Whereas
we observe that the difference in total cellular uptake is approxi-
mately 10-fold [21], the difference in lipid vesicle binding afﬁnity
between the three penetratin variants is less pronounced. The
quotient between the surface partition coefﬁcients for unlabeled
PenArg and PenLys in partly negatively charged membranes is for
example only around 3 [38]. In this study we used FITC-labeled
peptides throughout and whereas we have seen that this will increase
the lipid-mediated partitioning of all three penetratin variants into
octanol, we also showed that their relative partitioning was
independent of the label [37] suggesting that the more accentuated
differences that we observe here cannot be caused by the label itself.
In addition, we estimated the relative intrinsic afﬁnity of the peptides
for the lipid portion of the PMVs using the experimentally derived
Wimley andWhite hydrophobicity scale [62]. The difference between
PenArg and PenLys amounts to 1.26 kcal/mol which corresponds to a
binding constant ratio (KPA/KPL) of ~8. This value is smaller than the
ratio obtained above for the afﬁnity for PMVs (≥34). Moreover, all
peptides have net positive free energy changes for partitioning into
POPC membranes according to the Wimley and Whites hydropho-
bicity scale and it has in fact been shown that penetratin variants do
not interact signiﬁcantly with purely zwitterionic membranes [63]
indicating that negatively charged entities on the plasma membrane
are needed for binding. A plausible explanation for these discrepan-
cies is therefore that the penetratin peptides primarily associate withnegatively charged heparan sulfates on the cell surface and that the
relativemagnitude of these interactions would be sufﬁcient to explain
the observed differences in uptake. However, according to measures
in the literature, the dissociation constants for interaction with
heparin differ only by a factor 2–3 between individual arginine and
lysine residues [40]. Even though these values may not be directly
comparable to the exact dissociation constants of penetratin, PenArg
and PenLys, this gives a good indication that the differences in heparin
afﬁnity will be smaller than the differences in cell uptake. While it is
difﬁcult to directly compare data obtained in different model systems
our ﬁndings therefore indicate that the complexity and the molecular
organization of binding sites on the PMV surface may in fact be
important to adequately describe the relation between cell surface
afﬁnity and uptake efﬁciency.
Since PMVs do differ somewhat in composition from the cell
surface potentially displaying a slight enrichment in cholesterol and
sphingomyelin [43] and some alteration in transbilayer distribution of
phosphatidylethanolamine (PE) [64], and since the preparation
method involves low concentrations of cross-linking agents (5% of
what is normally used for cell ﬁxation) which could cause membrane
protein denaturation, we wished to conﬁrm that the PMVs would still
be representative models of the cell surface. To this end, wemeasured
the afﬁnity of the penetratin peptides to the cell surface of CHO-K1
cells kept at 4 °C to avoid endocytosis and compared these data to the
afﬁnity for PMVs.We found that there is a linear relationship between
cell surface binding and PMV afﬁnity (Fig. S2) which in turn suggests
that the composition of the PMV surface is sufﬁciently similar to that
of the plasma membrane of the live cells from which these vesicles
were derived.
We then compared the amount of peptide in the pelleted fractions
(calculated as the difference between applied peptide and peptide in
the supernatant, Fig. 5B) to the total cellular uptake in CHO-K1 cells
after 1 h incubation [21]. At this time-point internalization had
reached a plateau (Fig. S3). We obtained similar linear relationships
between these two parameters for each of the three peptides
examined (Fig. 6). This suggests that cell uptake of penetratin is
indeed occurring through adsorptive endocytosis and that cell surface
afﬁnity is a major determinant for cell uptake efﬁciency. This
conclusion is in contrast to a claim that no such relations exist
[50,51] but in accord with a recent study of the Tat peptide [65] and
early observations by Drin et al. [49]. Still, we have previously shown
that penetratin and its two analogs can stimulate macropinocytosis
1866 H.L. Åmand et al. / Biochimica et Biophysica Acta 1808 (2011) 1860–1867[21]. Such triggering of uptake is not immediately consistent with the
present ﬁnding and a possible explanation to this could be that
whereas a certain subset of the interactions are responsible for
initiating endocytosis, the bulk of internalized peptide is simply co-
internalized because it is bound to the cell-surface. One speciﬁc CPP
binding site has indeed recently been proposed [31] suggesting that
particular heparan sulfate interactions trigger endocytosis. It is
possible, given the strong electrostatic nature of CPP-target in-
teractions, that an increase in overall membrane afﬁnity also results
in increased binding to such particular “triggering sites”, but from our
data we cannot exclude that efﬁcient binding of the penetratin
peptides requires simultaneous interactions with several binding
sites. Further, our data support that the superior uptake-promoting
capability of arginine compared to lysine to a large extent is related to
its higher cell-surface afﬁnity.
4. Conclusions
This study evidences that penetratin peptideswithdifferent arginine
content bind to a plasma membrane vesicle model of the CHO-K1 cell
surface to an extent that correlates quantitatively with uptake in these
cells. Our ﬁndings substantiate the intuitive, but previously uncon-
ﬁrmed view that strong afﬁnity for the cell surface is a key property for
extensive CPP internalization. This suggests that the degree of endocytic
stimulation these peptides evoke is directly related to the amount of
peptide tightly bound to the cell surface. The study demonstrates the
usefulness of plasma membrane vesicles as cell membrane models in
biophysical studies of cell surface interactions and that a top–down
approach in design of cell-mimicking membrane models has the
potential to provide novel and detailed molecular understanding of
how CPPs interact with the cell membrane.
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